Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sinovac Expands Production Capacity
At the site, Sinovac Beijing is expecting to manufacture the enterovirus 71 (EV71) vaccine, which causes hand, foot and mouth disease (HFMD), and its other currently marketed flu
At the site, Sinovac Beijing is expecting to manufacture the enterovirus 71 (EV71) vaccine, which causes hand, foot and mouth disease (HFMD), and its other currently marketed flu
The grant is provided for Biotechnology Readiness, Immersion, Certification and Degrees for Gainful Employment (BRIDGE) project, which will provide education, training and placement services to veterans, incumbent workers
Reportedly, Abbott will add around $2.9bn to Abbott’s 2010 total reported sales and $500m to Abbott’s annual pharmaceutical R&D investment. Miles White, chairman and chief executive officer of
Fostamatinib disodium, which has completed Phase II programme, is the furthest developed oral Spleen Tyrosine Kinase (Syk) inhibitor being evaluated for RA. Under the agreement, AstraZeneca will make
Kim Bjornstrup, deputy chairman of Octapharma Group, said: “The development of our novel 10% IVIG is part of our ongoing commitment to invest in the development of protein
Quarterly non-GAAP net income was $847m, an increase of 28% compared to same period an year ago. Annual non-GAAP net income $3 billion, an increase of 22% compared
Reportedly, this LOI is additional to the LOI received by Henderson on October 8, 2009. As announced on November 25, 2009, Henderson submitted an orphan designation application to
With the use of high definition video conferencing equipment and collaboration software, pharmaceutical manufacturers now have access to GMP consultation services on-demand. VPCI claimed that ‘Virtual GMP Consulting’
Linguamatics witnessed corporate growth in 2009, with the addition of new pharmaceutical customers combined with expansion in deployment of the I2E semantic knowledge-discovery platform within existing customers. Linguamatics
The growth is primarily driven by exploration of factors influencing cellular malfunction and disease development. Additionally, innovations in epigenetic studies such as biomarker discovery and scientifically useful biomarker